← Open Payments lookup

JENNA SHERIDAN: Open Payments

NPI 1912367517 · BOSTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,508 in 73 payments from 14 companies in 2025. Trend: 2023 $1,281 · 2024 $1,182 · 2025 $1,508

Food & beverage: $1,508
CompanyPaymentsAmount
Incyte Corporation13$250
ABBVIE INC.16$239
Janssen Biotech, Inc.11$184
UCB, Inc.2$144
Amgen Inc.5$142
Lilly USA, LLC6$127
SUN PHARMACEUTICAL INDUSTRIES INC.5$96
Galderma Laboratories, L.P.5$94
Novartis Pharmaceuticals Corporation3$80
GENZYME CORPORATION2$54

Products named: OPZELURA, TREMFYA, SKYRIZI, Bimzelx, Otezla, TALTZ, DUPIXENT, RINVOQ.

Industry payments across MA — which companies pay providers there.